This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Gabapentin: Difference between revisions
Jump to navigation
Jump to search
>Josikins m Text replacement - "'''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>See responsible use section.</u><br> '''DISCLAIMER:''' PW's dosage information is a summary of data gathered from users and resources. It is not a recommendation and should be verified with other sources for accuracy." to "'''WARNING:''' Always start with lower doses due to differences between... |
>Josikins m Text replacement - "'''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>See responsible use section.</u><br> '''DISCLAIMER:''' PW's dosage information is a summary of data gathered from users and resources. It is NOT a recommendation and should be verified with other sources for accuracy." to "'''WARNING:''' Always start with lower doses due to differences between... |
||
| Line 52: | Line 52: | ||
|OralROA=true | |OralROA=true | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's dosage information is a summary of data gathered from users and resources. It is | |OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's dosage information is a summary of data gathered from users and resources. It is not a recommendation and should be verified with other sources for accuracy. | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold= | |OralROA_Threshold= | ||
Revision as of 04:27, 25 February 2016
| SubstanceBox/Gabapentin | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||
 |
|||||||||||||||
| Chemical Nomenclature | |||||||||||||||
| Common names | GABApentin, Neurontin, Gabarone, Gralise | ||||||||||||||
| Substitutive name | 1-(aminomethyl)cyclohexaneacetic acid | ||||||||||||||
| Class Membership | |||||||||||||||
| Psychoactive class | Depressant | ||||||||||||||
| Chemical class | GABAergic | ||||||||||||||
| Routes of Administration | |||||||||||||||
|
|||||||||||||||